2Parham DM,Ellison DA.Rhabdomyosarcomas in adults and children:an update[J].Arch Pathol Lab Med,2006,130(10):1454-1465.
3Qualman S,Lynch J,Bridge J,et al.Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma:a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group[J].Cancer,2008,113(11):3242-3247.
4Davicioni E,Anderson MJ,Finckenstein FG,et al.Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis:a report from the Children's Oncology Group[J].Am J Pathol,2009,174(2):550-564.
5Parham DM,Qualman SJ,Teot L,et al.Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma:a report from the Children's Oncology Group[J].Am J Surg Pathol,2007,31 (6):895-901.
6Davicioni E,Finckenstein FG,Shahbazian V,et al.Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas[J].Cancer Res,2006,66(14):6936-6946.
7Krsková L,Mrhalová M,Sumerauer D,et al.Rhabdomyosarcoma:molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement[J].Virchows Arch,2006,448(4):449-458.
9Schurch W,Begin LR,Seemayer TA,et al.Heomorphic soft tissue myogenic sarcomas of adulthood.A reappraisal in the mid-1990s[J].Am J Surg Pathol,1996,20:131-147.
10Sultan I,Qaddoumi I,Yaser S,et al.Comparing adult and pediatric rhabdomyosarcoma in the surveillance,epidemiology and end results program,1973 to 2005:an analysis of 2,600 patients[J].J Clin Oncol,2009,27(20):3391-3397.
3[2]Hawkins DS,Anderson JR,Paidas CN,et al.Improved outcome for patients with middle ear rhabdomyosarcoma:a children's oncology group study.J Chin Oncol,2001,19(12):3073-3079.
4[3]Donaldson SS,Castro JR,Wilbur JR,et al.Rhabdomyosarcoma of head and neck in children.Cancer,1973,31(1):26-35.
5[4]Eusebi V,Ceccarelli C,Gorza L,et al.Immunocytochemistry of rhabdomyosarcoma.The use of four different markers.Am J Surg Pathol,1986,10(4):293-299.
6[5]Weiss SW,Goldblum JR,Enzinger FM.Enzinger and Weiss's soft tissue tumors[M].4th ed.St.Louis:Mosby,2001:785-835.
7Wiener ES, Lawrence W, Hays D,et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. J Pediatr Surg,1994, 29:171.
8Hughes LL, Baruzzi MJ, Ribeiro RC, et al. Paratesticular rhabdomyosarcoma; Delayed effects of multimodality therapy and implications for current management. Cancer, 1994, 73:476.
9Ferrari A, Casanova M, Massimino M,et al The management of paratesticular rhabdomyosarcoma: A single institutional experience with 44 consecutive children. J Urol,1998,l59:1031.
10Costa MA, Schaum MR, Silva LF, et al. Rhabdomyosarcoma (RMS) in late adolescence and adulthood (Meeting Abstract).Meet Am Soc Clin Oncol, 1994, 13:A1660.
